Donald Trump’s return to the White House raises fresh questions about whether the U.S. can avoid a renewed Cold War with ...

Investing.com -- Jefferies upgraded Abbott Laboratories (NYSE: ABT) to Buy from Hold, calling the market reaction to the ...

The Dallas-based bank reported adjusted earnings per share of $0.56 for the quarter ended June 30, 2025, surpassing the analyst consensus of $0.54. Revenue totaled $109.83 million, just below the ...

Investing.com -- Pop Culture Group Co Ltd (NASDAQ: CPOP) stock surged 25% after the Chinese cultural content company announced plans to enter the cryptocurrency sector with initiatives set to launch ...

According to the company, Telomir-1 may reactivate the body’s natural tumor suppressor system by restoring STAT1 activity, potentially allowing immune cells to recognize and eliminate cancer cells.

Investing.com -- Mesoblast Ltd (NASDAQ: MESO) stock surged 25% after the company reported its first quarter of sales for its newly approved drug Ryoncil, which generated $13.2 million in gross revenue ...

The outlook change follows WPP’s July 9 trading update, which reported an organic decline of 4.2%-4.5% in revenue less pass-through costs for the first half of 2025. The company also lowered its ...

Investing.com -- S&P Global (NYSE: SPGI) Ratings has revised its outlook on Spain-based insurer Mapfre (BME: MAP) Group to positive from stable, citing improving capital and earnings generation.